Perrigo Verdict Could Bolster Store Brand Equivalency Claims
This article was originally published in The Tan Sheet
Executive Summary
A federal court jury ruled Perrigo did not falsely advertise when it claimed its private label glucosamine and chondroitin supplements are comparable to Rexall Sundown's Osteo Bi-Flex joint care products
You may also be interested in...
Supplement Claim Review Program Sees Cooperation, NAD Says
The National Advertising Division says its targeted review of dietary supplement advertising claims is increasing compliance, with most firms cooperating
Osteo Bi-Flex Claims Score Partial Victory In Appeal Of NAD Recommendation
The National Advertising Division's review board upheld most points of a recommendation that Rexall Sundown stop making certain claims for Osteo Bi-Flex dietary supplements, but said some claims can be used in ads and on packaging if "they are clearly qualified.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC